Bayer

BAYN.DE Large Cap

Healthcare · Drug Manufacturers - General

Updated: Apr 5, 2026, 00:03 UTC

€39.70

-1.06% today

52W: €18.38 – €49.78

52W Low: €18.38 Position: 67.9% 52W High: €49.78

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

8.38x

Forward Price/Earnings

P/S Ratio

0.86x

Price-to-Sales

EV/EBITDA

7.76x

Enterprise Value/EBITDA

Div. Yield

28%

Annual dividend yield

Market Cap

$39B

Market Capitalization

Revenue Growth

-2.5%

YoY Revenue Growth

Profit Margin

-7.94%

Net profit margin

ROE

-12.37%

Return on Equity

Beta

0.89

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

3,873,237

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

19 analysts

Avg. Price Target

€46.53

+17.2% upside

Target Range

€23.00 – €60.00

🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →

About the Company

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health

Sector: Healthcare Industry: Drug Manufacturers - General Country: Germany Employees: 87,280 Exchange: GER